TB-500 is thought to lower inflammation at the cellular level, which may help reduce swelling and stiffness in an injured knee
Emerging regulatory paradigms in glutathione metabolism
The activation of serine biosynthesis pathway enhances NADPH generation in cancer cells
When intra-portal insulin levels are increased (e.g., obesity, Cushings syndrome, or due to treatment with glucocorticoids and glucagon-like peptide 1 receptor agonists) or decreased (e.g., malnutrition, anorexia nervosa and type 1 diabetes mellitus), these changes secondarily alter hepatic GH sensitivity resulting in a secondary association with discordant GH and IGF-I levels (e.g., high GH/low IGF-I levels or low GH/high IGF-I levels, respectively)
Thats why all peptides should be carefully administered under the guidance of a clinical research trial or a qualified physician
References Kommu, S., Whitfield, P